Clinical Effect of Bifico Combined Olsalazine in Treating Ulcerative Colitis

Objective To Observe the clinical efficacy of bifico combined Olsalazine in the treatment of ulcerative colitis.Methods 43 cases of mild to moderate ulcerative colitis who diagnosed by Colonoscopy were randomly divided into treatment group(22 cases) and control group(21 cases).Treatment group was given bifico 420mg,orally,three times a day,olsalazine 1.0,orally,four times a day;The control group were given Olsalazine 1.0,orally,four times a day;treatment were 8 weeks.Symptom score were recorded after treatment.We reviewed colonoscopy and and taked pathological histological changes.Results Excellence rate,the total effective rate were 40.9% and 90.9%.In control group was 28.6% and 76.2%(P0.05).Conclusion Bifico combined olsalazine treatment of ulcerative colitis is better than alone olsalazine.